NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 58 filers reported holding NEURODERM LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,752,000 | +5260.0% | 96,452 | +4004.3% | 0.00% | – |
| Q2 2017 | $70,000 | +288.9% | 2,350 | +240.1% | 0.00% | – |
| Q1 2017 | $18,000 | -56.1% | 691 | -62.5% | 0.00% | – |
| Q4 2016 | $41,000 | +46.4% | 1,845 | +22.6% | 0.00% | – |
| Q3 2016 | $28,000 | +21.7% | 1,505 | +7.0% | 0.00% | – |
| Q2 2016 | $23,000 | +187.5% | 1,406 | +158.9% | 0.00% | – |
| Q1 2016 | $8,000 | -70.4% | 543 | -65.2% | 0.00% | – |
| Q4 2015 | $27,000 | -18.2% | 1,560 | -3.1% | 0.00% | – |
| Q3 2015 | $33,000 | +65.0% | 1,610 | +23.6% | 0.00% | – |
| Q2 2015 | $20,000 | +42.9% | 1,303 | +23.9% | 0.00% | – |
| Q1 2015 | $14,000 | +40.0% | 1,052 | +45.1% | 0.00% | – |
| Q4 2014 | $10,000 | – | 725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |